Possible contribution of IGF-1 to depressive disorder

Pharmacological Reports

Volumn 65, Issue 6, 2013, Pages 1622-1631

  Szczêsny, Ewa ^a   OElusarczyk, Joanna ^a   Glombik, Katarzyna ^a   Budziszewska, Boguslawa ^a   Kubera, Marta ^a   Lasoñz, Wladyslaw ^a   Basta Kaim, Agnieszka ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Antidepressant and anti inflammatory action; Depression; Insulin like growth factor (IGF) family; Neuroprotection; Neurotrophic factors

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; MESSENGER RNA; NEUROTROPHIC FACTOR; SOMATOMEDIN; SOMATOMEDIN C;

BDNF GENE; BIOLOGICAL ACTIVITY; BRAIN REGION; CLINICAL STUDY; DEPRESSION; DISEASE COURSE; DOWN REGULATION; EXPERIMENTAL STUDY; GENE CONTROL; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NERVOUS SYSTEM DEVELOPMENT; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

ANIMALS; ANTIDEPRESSIVE AGENTS; CENTRAL NERVOUS SYSTEM; DEPRESSIVE DISORDER; HUMANS; INSULIN-LIKE GROWTH FACTOR I; NERVE GROWTH FACTORS; NEURONAL PLASTICITY;

EID: 84894111139     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(13)71523-8     Document Type: Article

References (43)

1. Aberg MA, Aberg ND, Hedbäcker H, Oscarsson J, Eriksson PS: Peripheral infusion of IGF-I selectively induces neurogenesis in the adult rat hippocampus. J Neurosci, 2000, 20, 2896-2903. (Pubitemid 30220315)
2. Aguado F, Carmona MA, Pozas E, Aguiló A, Martínez-Guijarro FJ, Alcantara S, Borrell V et al.: BDNF regulates spontaneous correlated activity at early developmental stages by increasing synaptogenesis and expression of the K+/Cl. co-transporter KCC2. Development, 2003, 130, 1267-1280. (Pubitemid 36410776)
3. Annuziata M, Granata R, Ghigo E: The IGF system. Acta Diabetol, 2011, 48, 1-9.
4. Barreto RA, Walker FR, Dunkley PR, Day TA, Smith DW: Fluoxetine prevents development of an early stress-related molecular signature in the rat infralimbic medial prefrontal cortex. Implications for depression? BMC Neurosci, 2012, 13, 125-142.
5. Bezchlibnyk YB, Xu L, Wang JF, Young LT: Decreased expression of insulin-like growth factor binding protein 2 in the prefrontal cortex of subjects with bipolar disorder and its regulation by lithium treatment. Brain Res, 2007, 1147, 213-217. (Pubitemid 46574546)
6. Bluthé RM, Kelley KW, Dantzer R: Effects of insulinlike growth factor-I on cytokine-induced sickness behavior in mice. Brain Behav Immun, 2006, 20, 57-63. (Pubitemid 41814664)
7. Cieoelik K, Sowa-Kuæma M, Ossowska G, Legutko B, Wolak M, Opoka W, Nowak G: Chronic unpredictable stress-induced reduction in the hippocampal brainderived neurotrophic factor (BDNF) gene expression is antagonized by zinc treatment. Pharmacol Rep, 2011, 63, 537-543.
8. Dantzer R, Gheusi G, Johnson RW, Kelley KW: Central administration of insulin-like growth factor-1 inhibits lipopolysaccharide-induced sickness behavior in mice. Neuroreport, 1999, 10, 289-292. (Pubitemid 29104801)
9. Duman R: Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med, 2004, 5, 11-25. (Pubitemid 38391953)
10. Erabi K, Morinobu S, Kawano K, Tsuji S, Yamawaki S: Neonatal isolation changes the expression of IGF-IR and IGFBP-2 in the hippocampus in response to adulthood restraint stress. Int J Neuropsychopharmacol, 2007, 10, 369-381. (Pubitemid 46701001)
11. Grunbaum-Novak N, Taler M, Gil-Ad I, Weizman A, Cohen H, Weizman R: Relationship between antidepressants and IGF-1 system in the brain: Possible role in cognition. Eur Neuropsychopharmacol, 2008, 18, 431-438. (Pubitemid 351608552)
12. Guan J, Bennet L, Gluckman PD, Gunn AJ.: Insulin-like growth factor-1 and post-ischemic brain injury. Prog Neurobiol, 2003, 70, 443-462. (Pubitemid 37249426)
13. Hellweg R, Lang UE, Nagel M, Baumgartner A: Subchronic treatment with lithium increases nerve growth factor content in distinct brain regions of adult rats. Mol Psychiatry, 2002, 7, 604-608.
14. Hoshaw BA, Hill TI, Crowley JJ, Malberg JE, Khawaja X, Rosenzweig-Lipson S, Schechter LE, Lucki I: Antidepressant-like behavioral effects of IGF-1 produced by enhanced serotonin transmission. Eur J Pharmacol, 2008, 594, 109-116.
15. Hoshaw BA, Malberg JE, Lucki I: Central administration of IGF-I and BDNF leads to long-lasting antidepressantlike activity. Brain Res, 2005, 1037, 204-208. (Pubitemid 40362398)
16. Jiang C, Salton SR: The role of neurotrophins in major depressive disorder. Transl Neurosci, 2013, 4, 46-58.
17. Jones JI, Clemmons DR: Insulin-like growth factors and their binding proteins: Biological actions. Endocr Rev, 1995, 16, 3-34.
18. Khawaja X, Xu J, Liang JJ, Barrett JE: Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: Implications for depressive disorders and future therapies. J Neurosci Res, 2004, 75, 451-460. (Pubitemid 38160706)
19. Kitagishi Y, Kobayashi M, Kikuta K, Matsuda S: Roles of PI3K/AKT/GSK3/mTOR pathway in cell signaling of mental illnesses. Depress Res Treat, 2012, 752563, 1-8.
20. Lee KY, Miki T, Yokoyama T, Ueki M, Warita K, Suzuki S, Ohta K et al.: Neonatal repetitive maternal separation causes long-lasting alterations in various neurotrophic factor expression in the cerebral cortex of rats. Life Sci, 2012, 90, 578-584.
21. Li YJ, Xu M, Gao ZH, Wang YQ, Yue Z, Zhang YX, Li XX et al.: Alterations of serum levels of BDNFrelated miRNAs in patients with depression. PLoS One, 2013, 8, e63648, 1-7.
22. Malberg JE, Platt B, Rizzo SJ, Ring RH, Lucki I, Schechter LE, Rosenzweig-Lipson S: Increasing the levels of insulin-like growth factor-I by an IGF binding protein inhibitor produces anxiolytic and antidepressant-like effects. Neuropsychopharmacology, 2007, 32, 2360-2368. (Pubitemid 47587671)
23. Martino M, Rocchi G, Escelsior A, Contini P, Colicchio S, de Berardis D, Amore M et al.: NGF serum levels variations in major depressed patients receiving duloxetine. Psychoneuroendocrinology, 2013, 38, 1824-1828.
24. Masi G, Brovedani P: The hippocampus, neurotrophic factors and depression: Possible implications for the pharmacotherapy of depression. CNS Drugs, 2011, 25, 913-931.
25. Matheny RW, Nindl BC, Adamo ML: Minireview: Mechano-growth factor: A putative product of the IGF-I gene expression involved in tissue repair and regeneration. Endocrinology, 2010, 151, 865-875.
26. McCusker RH, McCrea K, Zunich S, Dantzer R, Broussard SR, Johnson RW, Kelley KW: Insulin-like growth factor-I enhances the biological activity of brain-derived neurotrophic factor on cerebrocortical neurons. J Neuroimmunol, 2006, 9,186-190. (Pubitemid 44441590)
27. Miguel-Hidalgo JJ, Rajkowska G: Morphological brain changes in depression: Can antidepressants reverse them? CNS Drugs, 2002, 16, 361-372. (Pubitemid 34638926)
28. Mitschelen M, Yan H, Farley JA, Warrington JP, Han S, Hereñú CB, Csiszar A et al.: Long-term deficiency of circulating and hippocampal insulin-like growth factor I induces depressive behavior in adult mice: A potential model of geriatric depression. Neuroscience, 2011, 185, 50-60.
29. O'Connor JC, McCusker RH, Strle K, Johnson RW, Dantzer R, Kelley KW: Regulation of IGF-I function by proinflammatory cytokines: At the interface of immunology and endocrinology. Cell Immunol, 2008, 252, 91-110.
30. Palomino A, González-Pinto A, Martinez-Cengotitabengoa M, Ruiz de Azua S, Alberich S, Mosquera F, Matute C: Relationship between negative symptoms and plasma levels of insulin-like growth factor 1 in firstepisode schizophrenia and bipolar disorder patients. Prog Neuropsychopharmacol Biol Psychiatry, 2013, 44, 29-33.
31. Pang Y, Campbell L, Zheng B, Fan L, Cai Z, Rhodes P: Lipopolysaccharide- activated microglia induce death of oligodendrocyte progenitor cells and impede their development. Neuroscience, 2010, 166, 464-475.
32. Park SE, Dantzer R, Kelley KW, McCusker RH: Central administration of insulin-like growth factor-I decreases depressive-like behavior and brain cytokine expression in mice. J Neuroinflamm, 2011, 8, 1-14.
33. Park SE, Lawson M, Dantzer R, Kelley KW, McCusker RH: Insulin-like growth factor-I pepides act centrally to decrease depression-like behavior of mice treated intraperitoneally with lipopolisaccharide. J Neuroinflamm, 2011, 8, 1-16.
34. Puzik A, Rupp J, Tröger B, Göpel W, Herting E, Härtel C: Insulin-like growth factor-I regulates the neonatal immune response in infection and maturation by suppression of IFN-g. Cytokine, 2012, 60, 369-376.
35. Randle PJ: Plasma-insulin activity in hypopituitarism assayed by the rat diaphragm method. Lancet, 1954, 266, 809-810.
36. Réus GZ, Stringari RB, Ribeiro KF, Cipriano AL, Panizzutti BS, Stertz L, Lersch C et al.: Maternal deprivation induces depressive-like behaviour and alters neurotrophin levels in the rat brain. Neurochem Res, 2011, 36, 460-466.
37. Russo VC, Gluckman PD, Feldman EL, Werther GA: The insulin-like growth factor system and its pleiotropic functions in brain. Endocr Rev, 2005, 6, 916-943. (Pubitemid 41770158)
38. Suh HS, Zhao ML, Derico L, Choi N, Lee SC.: Insulinlike growth factor 1 and 2 (IGF1, IGF2) expression in human microglia: Differential regulation by inflammatory mediators. J Neuroinflammation, 2013, 10, 37-53.
39. Supeno NE, Pati S, Hadi RA, Ghani AR, Mustafa Z, Abdullah JM, Idris FM et al.: IGF-1 acts as controlling switch for long-term proliferation and maintenance of EGF/FGF-responsive striatal neural stem cells. Int J Med Sci, 2013, 10, 522-531.
40. Torres-Aleman I:Toward a comprehensive neurobiology of IGF-I. Dev Neurobiol, 2010, 70, 384-396.
41. Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ: Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci, 2006, 9, 519-525.
42. Weber-Haman B, Blum WF, Kratzsch J, Gilles M, Heuser I, Deuschle M: Insulin-like growth factor-I (IGF-I) serum concentrations in depressed patients: Relationship to saliva cortisol and changes during antidepressant treatment. Pharmacopsychiatry, 2009, 42, 23-28.
43. Wysokiñski A, Gruszczyñski W: Neurotrophins-actual knowledge (Polish). Post Psychiat Neurol, 2008, 17, 385-390.